Coriell In The News
In an effort to refine their Reference Material initiative, the National Institute of Standards and Technology (NIST) will now offer samples from two family trios hosted in the Personal Genome Project Collection at Coriell Institute.
In the role of research scientist, Dr. Zajic contributes to the chief aims of Coriell's innovative precision medicine study.
A New Jersey publication has included Dr. Michael Christman in a roundup of business leaders.
Mark Bellafante, the new Chief Information Officer at Coriell, leads a dynamic group of IT professionals.
Insights provided by the Coriell Personalized Medicine Collaborative study informed a scientific perspective published in a genetics journal.
Dr. Laura Cosentino joins the Institute as the new director of biobanking logistics and quality standards.
In a recent publication, the CPMC research study group outlined a more comprehensive genotype-based dosing guide for the drug warfarin(Coumadin®).
Susan Delaney, director of government affairs and health policy at Coriell, was named to a 2016 "Best of Health Care" list.
Collaborating with key opinion leaders, Coriell contributed to a paper outlining perspectives and recommendations for employing genome and exome sequencing in the clinical setting.
Dr. Erin O'Shea, a former chair of the Coriell ICOB, has been named the new president of the Howard Hughes Medical Institute.
Meet our Team
Click here to meet our leadership and scientific staff.